Price Move History
- Daily moves over 5%
- 0 51 sessions, September 8, 2025 to September 8, 2026
- Largest daily move
- -3.8% close of October 7, 2025
- 1-year change
- +1.5% closing prices, September 8, 2025 to September 8, 2026
Company Description
AMEREN ILLINOIS 4.08 PFD (OTC: AILIH) is classified in the utilities - regulated electric industry within the Utilities sector.
AILIH has gained 1.5% over the past year. The last closing price was $66.00.
This page collects what Stock Titan holds for AILIH, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
AMEREN ILLINOIS 4.08 PFD (AILIH) closed at $66.00 on September 8, 2026. Over the past 12 months, the price has gained 1.5%.
AILIH Metrics & Rankings
Price returns through September 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
AMEREN ILLINOIS 4.08 PFD has filed 10 recent SEC filings, including 3 Form 8-K, 2 Form 10-Q, 1 Form 424B2, 1 Form 424B3. The most recent filing was submitted on August 24, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all AILIH SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in AMEREN ILLINOIS 4.08 PFD (AILIH) currently stands at 5 shares, down 66.7% from the previous reporting period, representing 0.0% of the float. Since September 2025, short interest has decreased by 66.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for AMEREN ILLINOIS 4.08 PFD (AILIH) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
AILIH Company Profile & Sector Positioning
AMEREN ILLINOIS 4.08 PFD (AILIH) operates in the Utilities - Regulated Electric industry within the broader Utilities sector and is listed on the OTC.